clinical trial · NCT04871711
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
LEO Pharma·phase3·completed·n = 487
Chronic Hand EczemaDelgocitinib creamCream vehicle
brief summary
This was a 16-week study in adult participants with chronic hand eczema (CHE). \> The participants visited the clinic regularly to have the study doctor assess their CHE and to answer questions about itch, pain, CHE symptoms, and quality of life. \> The purpose was to assess how delgocitinib cream works to treat CHE when compared to a placebo cream with no active substance.
started
May 10, 2021
primary completion
Oct 31, 2022
completion
Oct 31, 2022
last updated
Apr 8, 2025
official title
A Phase 3 Clinical Trial to Confirm Efficacy and Evaluate Safety of Twice-daily Delgocitinib Cream 20 mg/g Compared With Cream Vehicle for a 16-week Treatment Period in Adult Subjects With Moderate to Severe Chronic Hand Eczema (DELTA 1)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol